194 related articles for article (PubMed ID: 32462140)
1. Emerging vaccine manufacturers are innovating for the next decade.
Hayman B; Pagliusi S
Vaccine X; 2020 Aug; 5():100066. PubMed ID: 32462140
[TBL] [Abstract][Full Text] [Related]
2. Developing Countries Vaccine Manufacturers Network (DCVMN): engaging to step up for vaccine discovery and access. Meeting report 2012.
Pagliusi S; Makhoana M; Datla M; Leite L; Hendriks J; Gholami A; Huang W; Gao Y; Jadhav S; Harshavardhan GV; Wu Y; Suhardono M; Homma A
Vaccine; 2013 Jun; 31(31):3111-5. PubMed ID: 23684836
[TBL] [Abstract][Full Text] [Related]
3. Developing Countries Vaccine Manufacturers Network: doing good by making high-quality vaccines affordable for all.
Pagliusi S; Leite LC; Datla M; Makhoana M; Gao Y; Suhardono M; Jadhav S; Harshavardhan GV; Homma A
Vaccine; 2013 Apr; 31 Suppl 2():B176-83. PubMed ID: 23598479
[TBL] [Abstract][Full Text] [Related]
4. Role of vaccine manufacturers in developing countries towards global healthcare by providing quality vaccines at affordable prices.
Jadhav S; Gautam M; Gairola S
Clin Microbiol Infect; 2014 May; 20 Suppl 5():37-44. PubMed ID: 24476201
[TBL] [Abstract][Full Text] [Related]
5. Quality vaccines for all people: Report on the 16th annual general meeting of the Developing Countries Vaccine Manufacturers' Network, 05-07th October 2015, Bangkok, Thailand.
Pagliusi S; Ting CC; Khomvilai S;
Vaccine; 2016 Jun; 34(31):3562-7. PubMed ID: 26947496
[TBL] [Abstract][Full Text] [Related]
6. The art of partnerships for vaccines.
Pagliusi S; Che Y; Dong S
Vaccine; 2019 Sep; 37(40):5909-5919. PubMed ID: 31447125
[TBL] [Abstract][Full Text] [Related]
7. Vaccines, our shared responsibility.
Pagliusi S; Jain R; Suri RK;
Vaccine; 2015 May; 33(19):2197-2202. PubMed ID: 25749248
[TBL] [Abstract][Full Text] [Related]
8. Two decades of vaccine innovations for global public good: Report of the Developing Countries' Vaccine Manufacturers Network 20th meeting, 21-23 october 2019, Rio de Janeiro, Brazil.
Pagliusi S; Dennehy M; Homma A
Vaccine; 2020 Aug; 38(36):5851-5860. PubMed ID: 32535016
[TBL] [Abstract][Full Text] [Related]
9. Vaccines, inspiring innovation in health.
Pagliusi S; Dennehy M; Kim H;
Vaccine; 2018 Nov; 36(48):7430-7437. PubMed ID: 29789241
[TBL] [Abstract][Full Text] [Related]
10. Developing-country vaccine manufacturers' technical capabilities can make a difference in global immunization.
Hayman B; Dennehy M
Vaccine; 2021 Aug; 39(36):5153-5161. PubMed ID: 34362602
[TBL] [Abstract][Full Text] [Related]
11. The Developing Countries Vaccine Manufacturers' Network (DCVMN) is a critical constituency to ensure access to vaccines in developing countries.
Jadhav S; Datla M; Kreeftenberg H; Hendriks J
Vaccine; 2008 Mar; 26(13):1611-5. PubMed ID: 18294742
[TBL] [Abstract][Full Text] [Related]
12. Vaccines: Shaping global health.
Pagliusi S; Ting CC; Lobos F;
Vaccine; 2017 Mar; 35(12):1579-1585. PubMed ID: 28237501
[TBL] [Abstract][Full Text] [Related]
13. Emerging markets & emerging needs: developing countries vaccine manufacturers' perspective & its current status.
Jadhav SS; Gautam M; Gairola S
Biologicals; 2009 Jun; 37(3):165-8. PubMed ID: 19328010
[TBL] [Abstract][Full Text] [Related]
14. Better vaccines for healthier life. Part I. Conference report of the DCVMN International 14th Annual General Meeting Hanoi, Vietnam.
Pagliusi S; Rustan R; Huang W; Nguyen T;
Vaccine; 2014 Nov; 32(48):6325-9. PubMed ID: 24923636
[TBL] [Abstract][Full Text] [Related]
15. COVID-19 vaccine capacity: Challenges and mitigation - The DCVMN perspective.
Hayman B; Suri R; Prasad SD
Vaccine; 2021 Aug; 39(35):4932-4937. PubMed ID: 34325932
[TBL] [Abstract][Full Text] [Related]
16. Advancing innovation for vaccine manufacturers from developing countries: Prioritization, barriers, opportunities.
Hayman B; Bowles A; Evans B; Eyermann E; Nepomnyashchiy L; Pagliusi S
Vaccine; 2021 Feb; 39(8):1190-1194. PubMed ID: 33487466
[TBL] [Abstract][Full Text] [Related]
17. Landscape analysis of pharmacovigilance and related practices among 34 vaccine manufacturers' from emerging countries.
Hartmann K; Pagliusi S; Precioso A
Vaccine; 2020 Jul; 38(34):5490-5497. PubMed ID: 32591289
[TBL] [Abstract][Full Text] [Related]
18. Sustainable vaccine manufacturing in low- and middle-Income countries.
Hayman B; Kumar Suri R; Downham M
Vaccine; 2022 Nov; 40(50):7288-7304. PubMed ID: 36334966
[TBL] [Abstract][Full Text] [Related]
19. The Children's Vaccine Initiative and vaccine supply: the role of the public sector.
van Noort RB
Vaccine; 1992; 10(13):909-10. PubMed ID: 1471410
[TBL] [Abstract][Full Text] [Related]
20. Vaccines for a healthy future: 21st DCVMN Annual General Meeting 2020 report.
Pagliusi S; Hayman B; Jarrett S
Vaccine; 2021 Apr; 39(18):2479-2488. PubMed ID: 33838948
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
